Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC

A web tool for designing and conducting phase I trials using the continual reassessment method

8 p | 14 | 3

Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases

10 p | 9 | 2

A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma

9 p | 9 | 2

Triple modal treatment comprising with proton beam radiation, hyperthermia, and gemcitabine/nab-paclitaxel for locally advanced pancreatic cancer: A phase I/II study protocol (TT-LAP trial)

9 p | 5 | 2

Optimal biological dose: A systematic review in cancer phase I clinical trials

10 p | 13 | 1

Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: A prospective phase I subanalysis

10 p | 14 | 1

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

10 p | 10 | 1

Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: Interim analysis

12 p | 8 | 0

A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method

10 p | 14 | 0